Dr. Samuel E. Myrick III, MD

Dr. Myrick practices at Florida Cancer Affiliates Ocala, Tampa Bay, North Florida in Ocala, Florida.

Dr. Myrick's NPI, 1831180546, was assigned on November 2, 2005. Dr. Myrick graduated from University Of Florida College Of Medicine in 1994. Dr. Myrick holds Florida license ME90579.

Dr. Myrick's primary practice is Florida Cancer Affiliates Ocala, Tampa Bay, North Florida, at 3130 Sw 32nd Ave, Ocala, FL 34474-4445. The practice phone is (352) 732-4032.

Dr. Myrick's primary practice is Florida Cancer Affiliates Ocala, Tampa Bay, North Florida in Ocala, Florida. Dr. Myrick is also affiliated with HCA Florida Ocala Hospital. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Myrick to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Myrick practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Myrick's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Myrick is board certified in internal medicine by the American Board of Internal Medicine. Dr. Myrick is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Myrick treats.

CMS data shows 100,703 Medicare services from Dr. Myrick across 59 procedure codes in 2024, for 727 Medicare patients. Medicare paid $1,226,547 for them.

CMS counts 727 Medicare patients who saw Dr. Myrick in 2024. The largest group is 75 to 84, with 339 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Myrick's median patient age at 74, with 55% women.

In 2024, Dr. Myrick wrote 1,010 Medicare Part D claims for 212 patients. 78% of them were for generic drugs. CMS names the drug for 751 of them, across 26 drugs with 11 or more claims each, at $1,451,281 in total drug cost. In 2023, CMS named 674 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Myrick for performance year 2024, reported as part of a group. Dr. Myrick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Myrick in 2019. Dr. Myrick's most frequent co-authors are Patrick L. Stoner, DO and Ellen Mary Zimmermann, MD.

CMS Open Payments shows 1,833 general payments to Dr. Myrick from 99 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,762. It also lists 2 research payments totaling $30,240 from 2016 to 2017.

Dr. Myrick graduated from University Of Florida College Of Medicine in 1994.

Dr. Myrick is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.